Clinical Trials Browser

Phase 2 × INDUSTRY × Atypical Squamous Cells of the Cervix × Clear all

NCT07572396 2026-05-14

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities

Phase 2 Recruiting

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

NCT00896480 2021-04-08

Study of GSK2132231A Antigen-Specific Cancer Immunotherapeutic in Patients With Inoperable Metastatic Cutaneous Melanoma

Phase 2 Completed

24 enrolled 26 charts

Melanoma, Atypical Squamous Cells of the Cervix

NCT00312286 2016-09-23

Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.

Phase 2 Terminated

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Papillomavirus Infections, Atypical Squamous Cells of the Cervix